Mutual Fund Nov 2020 share holdings and fund action in Dr. Lal Pathlabs Ltd.

Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524

Expensive Performer

Download real time

2911.20 123.00 (4.41%)

32.26% Gain from 52W Low

1.2M NSE+BSE Volume

High volume today

NSE 25 Apr, 2025 3:31 PM (IST)

MF holding change 1Month %

1.3

MF holding change 2Month %

2.6

MF holding change 3Month%

Rapid Results

Q4FY25 Quarterly Result Announced for Dr. Lal Pathlabs Ltd. See details

MF	Nov-2020					Oct-2020		Sep-2020
MF	AUM (Rs Cr)	AUM %	Shares Held	Month Change in Shares	Month Change in Shares %	Shares Held	Month Change in Shares %	Shares Held	Month Change in Shares %
Canara Robeco Bluechip Equity Fund Regular Plan Growth	7.46	0.81%	32,500	5,000	18.18%	32,500	18.18%	27,500	100%
Canara Robeco Emerging Equities Growth	83.28	1.36%	362,586	20,000	5.84%	362,586	5.84%	342,586	0%
Canara Robeco Equity Hybrid Fund Growth	26.58	0.75%	115,721	0	0%	115,721	0%	115,721	0%
Canara Robeco ELSS Tax Saver Regular Payout of Income Dist cum Cap Wdrl	8.81	0.72%	38,339	-47,500	-55.34%	38,339	-55.34%	85,839	-0.58%
Canara Robeco Consumer Trends Fund Regular Plan Growth	5.16	1.22%	22,450	-15,300	-40.53%	22,450	-40.53%	37,750	0%
Canara Robeco Flexi Cap Fund Growth	26.50	1.08%	115,394	0	0%	115,394	0%	115,394	0%
LIC MF Large & Mid Cap Regular Growth	9.65	1.22%	42,000	0	0%	42,000	0%	42,000	0%
ITI Balanced Advantage Fund Regular Growth	-	-%	-	-	-%	0	-100%	7,098	100%
ITI Multi Cap Fund Regular Growth	-	-%	-	-	-%	0	-100%	5,350	100%
Motilal Oswal Nifty Midcap 150 Index Fund Regular Growth	0.49	0.63%	2,138	-55	-2.51%	2,193	5.48%	2,079	11.59%
Motilal Oswal Large and Midcap Fund Regular Growth	23.09	4.29%	100,790	0	0%	100,790	0%	100,790	0%
Motilal Oswal Nifty 500 Fund Regular Growth	0.07	0.09%	296	11	3.86%	285	12.20%	254	5.83%
Kotak Equity Opportunities Fund Growth	103.36	2.66%	450,000	0	0%	450,000	0%	450,000	0%
Motilal Oswal ELSS Tax Saver Fund Regular Plan Growth	59.22	3.32%	258,525	0	0%	258,525	0%	258,525	0%
Kotak Bluechip Growth	21.43	1.23%	93,289	13,289	16.61%	93,289	16.61%	80,000	17.38%
Kotak Balanced Advantage Fund Regular Growth	18.58	0.39%	80,872	0	0%	80,872	0%	80,872	-2.40%
Motilal Oswal Nifty Midcap 100 ETF	0.34	0.81%	1,498	-234	-13.51%	1,732	0.52%	1,723	3.05%
LIC MF Healthcare Fund Regular Growth	1.56	2.59%	6,793	475	7.52%	6,793	7.52%	6,318	6.76%
Tata India Pharma & Healthcare Fund Regular Growth	6.64	1.73%	29,000	0	0%	29,000	0%	29,000	123.08%
LIC MF Dividend Yield Fund Regular Growth	2.20	2.66%	9,585	0	0%	9,585	0%	9,585	0%
DSP Healthcare Fund Regular Growth	29.67	3.33%	129,172	0	0%	129,172	0%	129,172	0%
PGIM India Midcap Opportunities Fund Regular Growth	8.04	2.15%	35,000	10,000	40%	35,000	40%	25,000	0%
UTI Mid Cap Fund Regular Plan Growth	45.57	1.13%	198,410	0	0%	198,410	0%	198,410	0%
UTI Value fund Fund-Regular Plan Growth	30.78	0.70%	134,000	-5,119	-3.68%	134,000	-3.68%	139,119	0%
UTI Unit Linked Insurance	45.89	1.00%	199,811	-5,500	-2.68%	199,811	-2.68%	205,311	0%
Bank of India Small Cap Fund Regular Growth	1.20	1.49%	5,234	0	0%	5,234	0%	5,234	0%
UTI Healthcare Fund Regular Plan Growth	13.09	2.23%	56,988	0	0%	56,988	0%	56,988	7.26%
UTI Flexi Cap Fund Regular Plan Growth	276.50	2.32%	1,203,844	0	0%	1,203,844	0%	1,203,844	0%
Edelweiss Small Cap Fund Regular Growth	3.38	0.64%	14,728	0	0%	14,728	0%	14,728	-32.10%
Principal Emerging Bluechip Fund Growth	42.81	1.84%	186,900	0	0%	186,900	0%	186,900	0%
Quantum India ESG Equity Fund Regular Growth	0.24	0.95%	1,031	0	0%	1,031	0%	1,031	18.37%
Nippon India ETF Nifty Midcap 150	1.28	0.64%	5,583	-70	-1.24%	5,653	1.60%	5,564	9.01%
UTI Multi Asset Allocation Fund Regular Plan Growth	2.35	0.35%	10,231	0	0%	10,231	0%	10,231	0%
UTI Conservative Hybrid Fund Regluar Plan Growth	9.41	0.58%	40,954	-6,500	-13.70%	40,954	-13.70%	47,454	0%
Bank of India Large & Mid Cap Equity Fund Regular Growth	1.03	0.55%	4,500	0	0%	4,500	0%	4,500	0%
Edelweiss Mid Cap Fund Growth	6.12	0.60%	26,721	0	0%	26,721	0%	26,721	0%
Edelweiss Large & Mid Fund Growth	4.64	0.80%	20,277	0	0%	20,277	0%	20,277	0%
Edelweiss Aggressive Hybrid A Growth	0.08	0.40%	350	-173	-33.08%	523	0%	523	62.42%
Mahindra Manulife Aggressive Hybrid Fund Regular Growth	0.92	0.67%	4,000	0	0%	4,000	0%	4,000	0%
Mirae Asset Aggressive Hybrid Fund -Regular Plan-Growth	23.79	0.62%	103,568	0	0%	103,568	0%	103,568	-7.69%
Mirae Asset Healthcare Fund Regular Growth	35.31	3.41%	153,738	0	0%	153,738	0%	153,738	6.96%
ICICI Prudential BSE 500 ETF	0.04	0.11%	177	-8	-4.32%	177	-4.32%	185	0%
ICICI Prudential Nifty Midcap 150 ETF	0.19	0.65%	828	64	8.38%	764	-24.43%	1,011	17.29%
Mirae Asset Focused Fund Regular Growth	56.99	1.54%	248,108	0	0%	248,108	0%	248,108	0%
Mirae Asset Large & Midcap Fund Growth	113.12	0.95%	492,504	0	0%	492,504	0%	492,504	0%
Mirae Asset ELSS Tax Saver Fund -Regular Plan-Growth	6.49	0.15%	28,252	0	0%	28,252	0%	28,252	0%
Mirae Asset Midcap Fund Regular Growth	22.97	0.90%	100,000	-8,094	-7.49%	100,000	-7.49%	108,094	5.93%
HSBC Large and Mid Cap Fund - IDCW	9.19	1.84%	40,000	0	0%	40,000	0%	40,000	0%
Taurus Infrastructure Fund - Growth Option	0.04	0.90%	156	0	0%	156	100%	-	-%
Taurus Flexi Cap Fund - Growth	1.77	0.80%	7,736	2,000	34.87%	5,736	100%	-	-%
Total:			5,214,577	-37,714		5,213,034		5,258,851

32.26% Gain from 52W Low

High volume today

Canara Robeco Emerging Equities Growth was the highest buyer of 20,000 shares in Nov 2020 constituting 0.02% of the paid up equity of the company.

Canara Robeco ELSS Tax Saver Regular Payout of Income Dist cum Cap Wdrl was the highest seller of 47,500 shares in Nov 2020 constituting 0.06% of the paid up equity of the company.

Shareholding Stock Screeners

32.26% Gain from 52W Low

High volume today

Mutual Fund Nov 2020 share holdings and fund action in Dr. Lal Pathlabs Ltd.

8 MFs bought and 11 MFs sold Dr. Lal Pathlabs Ltd. in the month of Nov 2020 for a net change of 37,714 stocks

Canara Robeco Emerging Equities Growth was the highest buyer of 20,000 shares in Nov 2020 constituting 0.02% of the paid up equity of the company.

Canara Robeco ELSS Tax Saver Regular Payout of Income Dist cum Cap Wdrl was the highest seller of 47,500 shares in Nov 2020 constituting 0.06% of the paid up equity of the company.

Shareholding Stock Screeners